After establishing a 5-day PCPA-induced insomnia model, treatments were administered over a subsequent 7-day period
DONT use the nasal spray within 1 hour of using other nasal decongestants or allergy sprays, as this can wash the medicine away before it absorbs
Optionally, a controlled-release formulation includes otoprotective agents, such as antioxidants, alpha lipoic acid, calcium, fosfomycin or iron chelators, to counteract potential ototoxic effects that may arise from the use of specific therapeutic agents or excipients, diluents, or carriers
This lack of approval means they haven't been proven safe or effective through rigorous clinical trials
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Compatibility depends on the peptide and manufacturer instructions